Analysis of enterolignan glucuronides in serum and urine by HPLC-ESI-MS

A method involving the coupling of high-performance liquid chromatography with electrospray ionisation mass spectrometry (HPLC-ESI-MS) for the quantitative determination of the mammalian lignans enterolactone and enterodiol in human blood and urine has been developed. In contrast to techniques previ...

Full description

Saved in:
Bibliographic Details
Main Authors: Knust, Ulrike (Author) , Hull, William Edmund (Author) , Spiegelhalder, Bertold (Author) , Bartsch, Helmut (Author) , Strowitzki, Thomas (Author) , Owen, Robert (Author)
Format: Article (Journal)
Language:English
Published: 20 February 2006
In: Food and chemical toxicology
Year: 2006, Volume: 44, Issue: 7, Pages: 1038-1049
ISSN:1873-6351
DOI:10.1016/j.fct.2005.12.008
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.fct.2005.12.008
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0278691506000032
Get full text
Author Notes:U. Knust, W.E. Hull, B. Spiegelhalder, H. Bartsch, T. Strowitzki, R.W. Owen
Description
Summary:A method involving the coupling of high-performance liquid chromatography with electrospray ionisation mass spectrometry (HPLC-ESI-MS) for the quantitative determination of the mammalian lignans enterolactone and enterodiol in human blood and urine has been developed. In contrast to techniques previously published, the method allows direct measurement of free enterolignans as well as their monoglucuronide conjugates in human biofluids with minimal sample preparation. Thereby the method is suitable for large-scale intervention, case-control and epidemiologic studies. Comprehensive, high-precision 1H and 13C nuclear magnetic resonance data (CD3OD as solvent) obtained at 11.7T in combination with polarimetric data show that the major form of lignan precursor in the linseeds used is (−)-secoisolariciresinol diglucoside ((2R,3R)-2,3-bis(4′-hydroxy-3′-methoxy-benzyl)-1,4-butanediyl-bis-β-d-glucopyranoside) which is transformed by human intestinal bacteria into (+)-enterodiol and (+)-enterolactone. However, these metabolites are mono-glucuronidated after absorption and are detected as (−)-enterodiol 3′-β-d-glucuronide=(2R,3R)-2-(3′-O-(β-d-glucopyranosyluronic acid)benzyl)-3-(3″-hydroxybenzyl)-butane-1,4,diol and (−)-enterolactone 3′-β-d-glucuronide=(2R,3R)-2-(3′-O-(β-d-glucopyranosyluronic acid)benzyl)-3-(3″-hydroxybenzyl)-β-butyrolactone in blood and urine.
Item Description:Gesehen am 23.11.2020
Physical Description:Online Resource
ISSN:1873-6351
DOI:10.1016/j.fct.2005.12.008